Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,343.72
(
-0.39%
)
US TECH 100
22,241.20
(
-1.16%
)
Dow Jones
45,216.14
(
0.11%
)
Brent Oil
106.90
(
-1.54%
)
Bitcoin
67,453.21
(
1.13%
)
News Focus
News Focus

Replies to post #737113 on NorthWest Biotherapeutics Inc (NWBO)

Replies to #737113 on NorthWest Biotherapeutics Inc (NWBO)
icon url

learningcurve2020

12/12/24 1:50 PM

#737117 RE: georgebailey #737113

>>Vorasidenib is available in the UK via an early access scheme for LGG patients with IDH1/2 mutation who have had surgery but not radiotherapy/chemotherapy.
icon url

learningcurve2020

12/12/24 2:06 PM

#737126 RE: georgebailey #737113

Another one would be Tovorafenib.